Colossal Biosciences, the firm pioneering “de-extinction technologies” to restore threatened or even vanished species, announced a $60 million Series A.
Why it matters: The early stage funding announcement comes five months after Colossal raised $15 million in seed capital, bringing the company’s total funding to $75 million.
The big picture: The company straddles climate science and biotech — which is reflected in the investor makeup:
- The funding round was led by billionaire Thomas Tull, CEO of Tulco, as well as At One Ventures, which focuses on sustainability and regenerative technologies.
- It also included Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital, Arch Ventures co-founder Robert Nelsen, Bold Capital, Boost VC, Jazz Ventures, Builders VC, Green Sands Equity, Draper Associates, and Charles Hoskinson. Also, Paris Hilton.
To learn more click here